Nurotron Biotechnology Expands in Latin America

Share Article

Maker of cochlear implant system helps children, woman with severe hearing loss.

Nurotron Logo

Four individuals in Latin America – including three young boys – now have the sense of hearing, thanks to the donations and cooperative efforts of Nurotron Biotechnology Co., Ltd., , two physicians and medical device companies in Peru and Bolivia.

Surgeons in La Paz, Bolivia, and Lima, Peru, gave the gift of hearing with Nurotron’s Venus Cochlear Implant System. The system is an effective solution for children and adults suffering from severe and profound hearing loss. The surgeries were the first in Bolivia and Peru for Nurotron’s system.

In Peru, the Venus Cochlear Implant System is helping an 8-year-old orphan boy with multiple disabilities, and a 58-year-old woman. The child suffered from bilateral sensorinueral hearing loss, which occurs when there is damage to the inner ear, or cochlea, while the woman experienced progressive hearing loss. Dr. Javier Rubio performed both surgeries, with Dr. Juan Chiossone assisting. Both surgeries took place at La Clínica Delgado in Lima.

In Boliva, the Nurotron system is helping two brothers, ages 4 and 8. Both suffered from severe sensorineural hearing loss. The surgeries took place at Clinica del Sur in La Paz, with Dr. Jové Castro as surgeon and Chiossone assisting.

Dr. Rubio and Nurotron’s distributor in Peru, Surgicorp, made the surgeries possible, according to Chu Li, CEO of Nurotron. In the other case, Dr. Rubio provided special pricing that included rehabilitation costs. In Bolivia, Biopro, Nurotron’s distributor in that country, donated the implants themselves.

“These groundbreaking surgeries would never have been possible without the efforts and contributions of Surgicorp, Biopro and the physicians,” says Li. “The opportunity to work with all of these people to bring, or restore, hearing to individuals in South America, is one of Nurotron’s greatest opportunities.”

The four implants point to Nurotron’s worldwide growth, says Chu Li, CEO of the company. To date, doctors have performed surgeries with the Venus Cochlear Implant System in seven countries: China, Colombia, India, Turkey and Venezuela, and now Bolivia and Peru. Nurotron also holds the CE mark in Europe. “Nurotron’s expansion in the Latin American market gives it the opportunity to meet more and more of the worldwide demand for safe, reliable cochlear implants.”

Nurotron Biotechnology Co., Ltd. (
Nurotron Biotechnology is a medical device company that designs, develops and markets cochlear implant systems. The company’s flagship system is the Venus Cochlear Implant System, a safe, reliable and effective solution for children and adults suffering from severe and profound hearing loss. The global leader in cochlear implant technology maintains its research and development center in Irvine, Calif., and manufacturing facilities in China. Founded in 2006, Nurotron is headquartered in Hangzhou, China.


Share article on social media or email:

View article via:

Pdf Print

Contact Author

Aimee Bennett

Rick Giancola